Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis

Background. The use of anticoagulant therapy (ACT) in patients with acute infective endocarditis (IE) remains a controversial issue. Our study attempts to estimate the impact of ACT on the occurrence of embolic complications and the usefulness of ACT in the prevention of embolism in IE patients. Met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioMed research international 2014-01, Vol.2014 (2014), p.1-7
Hauptverfasser: Lim, Dal-Soo, Lee, Seung-Jae, Park, Jin-Sik, Choi, Rak-Kyeong, Hong, Suk-Keun, Oh, Sam-Sae
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7
container_issue 2014
container_start_page 1
container_title BioMed research international
container_volume 2014
creator Lim, Dal-Soo
Lee, Seung-Jae
Park, Jin-Sik
Choi, Rak-Kyeong
Hong, Suk-Keun
Oh, Sam-Sae
description Background. The use of anticoagulant therapy (ACT) in patients with acute infective endocarditis (IE) remains a controversial issue. Our study attempts to estimate the impact of ACT on the occurrence of embolic complications and the usefulness of ACT in the prevention of embolism in IE patients. Methods. The present authors analyzed 150 patients with left-sided IE. Embolisms including cerebrovascular events (CVE) and the use of ACT were checked at the time of admission and during hospitalization. Results. 57 patients (38.0%) experienced an embolic event. There was no significant difference in the incidence of CVE and in-hospital mortality between patients with and without warfarin use at admission, although warfarin-naïve patients were significantly more likely to have large (>1 cm) and mobile vegetation. In addition, there was no significant difference in the incidence of postadmission embolism and in-hospital death between patients with and without in-hospital ACT. On multivariate logistic regression analysis, ACT at admission was not significantly associated with a lower risk of embolism in patients with IE. Conclusions. The role of ACT in the prevention of embolism was limited in IE patients undergoing antibiotic therapy, although it seems to reduce the embolic potential of septic vegetation before treatment.
doi_str_mv 10.1155/2014/254187
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4119712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A427022323</galeid><sourcerecordid>A427022323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-eb6bac5017b3652334f710ddf2dff3435b774099a6e4575d2b4f904efe7299b23</originalsourceid><addsrcrecordid>eNqF0s1rFDEYB-BBFFvWnjwrAS-irM13Zi6FZVm1ULCH9hwymTc7KbPJOpnZUvCPN-PU9ePSXBKShx_Jm7coXhP8iRAhzikm_JwKTkr1rDiljPClJJw8P64ZOynOUrrDeZRE4kq-LE6oIARLqU6LH7cJ3NgFSAlFh1Zh8Daa7diZMKCbFnqzf0A-oKEFdN3DATKIYaKbXR07b9E67vZ5NtN-muh1XmaW0L0fWrSy4wDoMjiwgz8A2oQmWtM3fvDpVfHCmS7B2eO8KG4_b27WX5dX375crldXSyuoGpZQy9pYgYmqmRSUMe4UwU3jaOMc40zUSnFcVUYCF0o0tOauwhwcKFpVNWWL4mLO3Y_1Dhqbb9ebTu97vzP9g47G639Pgm_1Nh40J6RSZAp4_xjQx-8jpEHvfLLQ5SpBHJMmkhDJhMTiaSoELbGieEp99x-9i2MfciV-KVmWUqk_ams60D64mK9op1C94lRhSlkuyaL4OCvbx5R6cMfXEaynTtFTp-i5U7J--3dBjvZ3X2TwYQatD42590-kvZkxZALOHHH-DcUU-wmTq87C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552688677</pqid></control><display><type>article</type><title>Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Lim, Dal-Soo ; Lee, Seung-Jae ; Park, Jin-Sik ; Choi, Rak-Kyeong ; Hong, Suk-Keun ; Oh, Sam-Sae</creator><contributor>Conti, Alfredo</contributor><creatorcontrib>Lim, Dal-Soo ; Lee, Seung-Jae ; Park, Jin-Sik ; Choi, Rak-Kyeong ; Hong, Suk-Keun ; Oh, Sam-Sae ; Conti, Alfredo</creatorcontrib><description>Background. The use of anticoagulant therapy (ACT) in patients with acute infective endocarditis (IE) remains a controversial issue. Our study attempts to estimate the impact of ACT on the occurrence of embolic complications and the usefulness of ACT in the prevention of embolism in IE patients. Methods. The present authors analyzed 150 patients with left-sided IE. Embolisms including cerebrovascular events (CVE) and the use of ACT were checked at the time of admission and during hospitalization. Results. 57 patients (38.0%) experienced an embolic event. There was no significant difference in the incidence of CVE and in-hospital mortality between patients with and without warfarin use at admission, although warfarin-naïve patients were significantly more likely to have large (&gt;1 cm) and mobile vegetation. In addition, there was no significant difference in the incidence of postadmission embolism and in-hospital death between patients with and without in-hospital ACT. On multivariate logistic regression analysis, ACT at admission was not significantly associated with a lower risk of embolism in patients with IE. Conclusions. The role of ACT in the prevention of embolism was limited in IE patients undergoing antibiotic therapy, although it seems to reduce the embolic potential of septic vegetation before treatment.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2014/254187</identifier><identifier>PMID: 25110667</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Puplishing Corporation</publisher><subject>Acute Disease ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Aneurysms ; Antibiotics ; Anticoagulants ; Anticoagulants (Medicine) ; Anticoagulants - therapeutic use ; Cardiac arrhythmia ; Child ; Embolism - drug therapy ; Embolism - etiology ; Embolism - prevention &amp; control ; Embolization ; Endocarditis ; Endocarditis, Bacterial - complications ; Female ; Health aspects ; Heart ; Hemorrhage ; Hospitalization ; Hospitals ; Humans ; Infective endocarditis ; Kaplan-Meier Estimate ; Magnetic resonance imaging ; Male ; Medical records ; Meningitis ; Microorganisms ; Middle Aged ; Prostheses ; Pulmonary embolisms ; Regression analysis ; Risk Factors ; Stroke ; Time Factors ; Vegetation ; Veins &amp; arteries ; Young Adult</subject><ispartof>BioMed research international, 2014-01, Vol.2014 (2014), p.1-7</ispartof><rights>Copyright © 2014 Seung-Jae Lee et al.</rights><rights>COPYRIGHT 2014 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2014 Seung-Jae Lee et al. Seung-Jae Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2014 Seung-Jae Lee et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-eb6bac5017b3652334f710ddf2dff3435b774099a6e4575d2b4f904efe7299b23</citedby><cites>FETCH-LOGICAL-c527t-eb6bac5017b3652334f710ddf2dff3435b774099a6e4575d2b4f904efe7299b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119712/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119712/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25110667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Conti, Alfredo</contributor><creatorcontrib>Lim, Dal-Soo</creatorcontrib><creatorcontrib>Lee, Seung-Jae</creatorcontrib><creatorcontrib>Park, Jin-Sik</creatorcontrib><creatorcontrib>Choi, Rak-Kyeong</creatorcontrib><creatorcontrib>Hong, Suk-Keun</creatorcontrib><creatorcontrib>Oh, Sam-Sae</creatorcontrib><title>Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Background. The use of anticoagulant therapy (ACT) in patients with acute infective endocarditis (IE) remains a controversial issue. Our study attempts to estimate the impact of ACT on the occurrence of embolic complications and the usefulness of ACT in the prevention of embolism in IE patients. Methods. The present authors analyzed 150 patients with left-sided IE. Embolisms including cerebrovascular events (CVE) and the use of ACT were checked at the time of admission and during hospitalization. Results. 57 patients (38.0%) experienced an embolic event. There was no significant difference in the incidence of CVE and in-hospital mortality between patients with and without warfarin use at admission, although warfarin-naïve patients were significantly more likely to have large (&gt;1 cm) and mobile vegetation. In addition, there was no significant difference in the incidence of postadmission embolism and in-hospital death between patients with and without in-hospital ACT. On multivariate logistic regression analysis, ACT at admission was not significantly associated with a lower risk of embolism in patients with IE. Conclusions. The role of ACT in the prevention of embolism was limited in IE patients undergoing antibiotic therapy, although it seems to reduce the embolic potential of septic vegetation before treatment.</description><subject>Acute Disease</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aneurysms</subject><subject>Antibiotics</subject><subject>Anticoagulants</subject><subject>Anticoagulants (Medicine)</subject><subject>Anticoagulants - therapeutic use</subject><subject>Cardiac arrhythmia</subject><subject>Child</subject><subject>Embolism - drug therapy</subject><subject>Embolism - etiology</subject><subject>Embolism - prevention &amp; control</subject><subject>Embolization</subject><subject>Endocarditis</subject><subject>Endocarditis, Bacterial - complications</subject><subject>Female</subject><subject>Health aspects</subject><subject>Heart</subject><subject>Hemorrhage</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infective endocarditis</subject><subject>Kaplan-Meier Estimate</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical records</subject><subject>Meningitis</subject><subject>Microorganisms</subject><subject>Middle Aged</subject><subject>Prostheses</subject><subject>Pulmonary embolisms</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Stroke</subject><subject>Time Factors</subject><subject>Vegetation</subject><subject>Veins &amp; arteries</subject><subject>Young Adult</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqF0s1rFDEYB-BBFFvWnjwrAS-irM13Zi6FZVm1ULCH9hwymTc7KbPJOpnZUvCPN-PU9ePSXBKShx_Jm7coXhP8iRAhzikm_JwKTkr1rDiljPClJJw8P64ZOynOUrrDeZRE4kq-LE6oIARLqU6LH7cJ3NgFSAlFh1Zh8Daa7diZMKCbFnqzf0A-oKEFdN3DATKIYaKbXR07b9E67vZ5NtN-muh1XmaW0L0fWrSy4wDoMjiwgz8A2oQmWtM3fvDpVfHCmS7B2eO8KG4_b27WX5dX375crldXSyuoGpZQy9pYgYmqmRSUMe4UwU3jaOMc40zUSnFcVUYCF0o0tOauwhwcKFpVNWWL4mLO3Y_1Dhqbb9ebTu97vzP9g47G639Pgm_1Nh40J6RSZAp4_xjQx-8jpEHvfLLQ5SpBHJMmkhDJhMTiaSoELbGieEp99x-9i2MfciV-KVmWUqk_ams60D64mK9op1C94lRhSlkuyaL4OCvbx5R6cMfXEaynTtFTp-i5U7J--3dBjvZ3X2TwYQatD42590-kvZkxZALOHHH-DcUU-wmTq87C</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Lim, Dal-Soo</creator><creator>Lee, Seung-Jae</creator><creator>Park, Jin-Sik</creator><creator>Choi, Rak-Kyeong</creator><creator>Hong, Suk-Keun</creator><creator>Oh, Sam-Sae</creator><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis</title><author>Lim, Dal-Soo ; Lee, Seung-Jae ; Park, Jin-Sik ; Choi, Rak-Kyeong ; Hong, Suk-Keun ; Oh, Sam-Sae</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-eb6bac5017b3652334f710ddf2dff3435b774099a6e4575d2b4f904efe7299b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acute Disease</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aneurysms</topic><topic>Antibiotics</topic><topic>Anticoagulants</topic><topic>Anticoagulants (Medicine)</topic><topic>Anticoagulants - therapeutic use</topic><topic>Cardiac arrhythmia</topic><topic>Child</topic><topic>Embolism - drug therapy</topic><topic>Embolism - etiology</topic><topic>Embolism - prevention &amp; control</topic><topic>Embolization</topic><topic>Endocarditis</topic><topic>Endocarditis, Bacterial - complications</topic><topic>Female</topic><topic>Health aspects</topic><topic>Heart</topic><topic>Hemorrhage</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infective endocarditis</topic><topic>Kaplan-Meier Estimate</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical records</topic><topic>Meningitis</topic><topic>Microorganisms</topic><topic>Middle Aged</topic><topic>Prostheses</topic><topic>Pulmonary embolisms</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Stroke</topic><topic>Time Factors</topic><topic>Vegetation</topic><topic>Veins &amp; arteries</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lim, Dal-Soo</creatorcontrib><creatorcontrib>Lee, Seung-Jae</creatorcontrib><creatorcontrib>Park, Jin-Sik</creatorcontrib><creatorcontrib>Choi, Rak-Kyeong</creatorcontrib><creatorcontrib>Hong, Suk-Keun</creatorcontrib><creatorcontrib>Oh, Sam-Sae</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lim, Dal-Soo</au><au>Lee, Seung-Jae</au><au>Park, Jin-Sik</au><au>Choi, Rak-Kyeong</au><au>Hong, Suk-Keun</au><au>Oh, Sam-Sae</au><au>Conti, Alfredo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Background. The use of anticoagulant therapy (ACT) in patients with acute infective endocarditis (IE) remains a controversial issue. Our study attempts to estimate the impact of ACT on the occurrence of embolic complications and the usefulness of ACT in the prevention of embolism in IE patients. Methods. The present authors analyzed 150 patients with left-sided IE. Embolisms including cerebrovascular events (CVE) and the use of ACT were checked at the time of admission and during hospitalization. Results. 57 patients (38.0%) experienced an embolic event. There was no significant difference in the incidence of CVE and in-hospital mortality between patients with and without warfarin use at admission, although warfarin-naïve patients were significantly more likely to have large (&gt;1 cm) and mobile vegetation. In addition, there was no significant difference in the incidence of postadmission embolism and in-hospital death between patients with and without in-hospital ACT. On multivariate logistic regression analysis, ACT at admission was not significantly associated with a lower risk of embolism in patients with IE. Conclusions. The role of ACT in the prevention of embolism was limited in IE patients undergoing antibiotic therapy, although it seems to reduce the embolic potential of septic vegetation before treatment.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Puplishing Corporation</pub><pmid>25110667</pmid><doi>10.1155/2014/254187</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6133
ispartof BioMed research international, 2014-01, Vol.2014 (2014), p.1-7
issn 2314-6133
2314-6141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4119712
source MEDLINE; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access
subjects Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Aneurysms
Antibiotics
Anticoagulants
Anticoagulants (Medicine)
Anticoagulants - therapeutic use
Cardiac arrhythmia
Child
Embolism - drug therapy
Embolism - etiology
Embolism - prevention & control
Embolization
Endocarditis
Endocarditis, Bacterial - complications
Female
Health aspects
Heart
Hemorrhage
Hospitalization
Hospitals
Humans
Infective endocarditis
Kaplan-Meier Estimate
Magnetic resonance imaging
Male
Medical records
Meningitis
Microorganisms
Middle Aged
Prostheses
Pulmonary embolisms
Regression analysis
Risk Factors
Stroke
Time Factors
Vegetation
Veins & arteries
Young Adult
title Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A12%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20Anticoagulant%20Therapy%20in%20the%20Prevention%20of%20Embolic%20Complications%20in%20Patients%20with%20Acute%20Infective%20Endocarditis&rft.jtitle=BioMed%20research%20international&rft.au=Lim,%20Dal-Soo&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2014/254187&rft_dat=%3Cgale_pubme%3EA427022323%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1552688677&rft_id=info:pmid/25110667&rft_galeid=A427022323&rfr_iscdi=true